Monografie
High-sensitive cardiac troponin I (hs-cTnI) concentrations in newborns diagnosed with spinal muscular atrophy
- Sprache
-
Englisch
- Identifier
-
1313814237
- Beteiligte Personen und Organisationen
-
Johannsen, Jessika
Weiss, Deike
Driemeyer, Joenna
Olfe, Jakob Justus
Stute, Fridrike
Müller, Ferdinand
Schütt, Marion
Trollmann, Regina
Kölbel, Heike
Schara, Ulrike
Kirschner, Janbernd
Pechmann, Astrid
Blaschek, Astrid
Horber, Veronka
Denecke, Jonas
- DOI
-
10.3389/fped.2023.1259293
- URN
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
09.01.2024, 11:56 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Monografie
Beteiligte
- Johannsen, Jessika
- Weiss, Deike
- Driemeyer, Joenna
- Olfe, Jakob Justus
- Stute, Fridrike
- Müller, Ferdinand
- Schütt, Marion
- Trollmann, Regina
- Kölbel, Heike
- Schara, Ulrike
- Kirschner, Janbernd
- Pechmann, Astrid
- Blaschek, Astrid
- Horber, Veronka
- Denecke, Jonas
Ähnliche Objekte (12)
Diagnosis and management of spinal muscular atrophy : : Part 2
Treatment satisfaction in 5q-spinal muscular atrophy under nusinersen therapy
Costs of illness of spinal muscular atrophy: a systematic review
Defective Mitochondria Contribute to Impaired Translation in Spinal Muscular Atrophy
Cytoskeletal dysregulation in the motoneuron disease Spinal Muscular Atrophy (SMA)
Molecular mechanisms of cytoskeletal dysregulations in Spinal Muscular Atrophy (SMA)
J wave syndromes in patients with spinal and bulbar muscular atrophy
Targeting RNA structure in SMN2 reverses spinal muscular atrophy molecular phenotypes
Development of antisense oligonucleotide combinatorial therapies for spinal muscular atrophy (SMA)
Novel modifiers for inherited neurodegenerative disorders : spinal muscular atrophy and ataxia
Combination disease‐modifying treatment in spinal muscular atrophy: a proposed classification
Experiences from treating seven adult 5q spinal muscular atrophy patients with Nusinersen
Diagnosis and management of spinal muscular atrophy : : Part 2
Treatment satisfaction in 5q-spinal muscular atrophy under nusinersen therapy
Costs of illness of spinal muscular atrophy: a systematic review
Defective Mitochondria Contribute to Impaired Translation in Spinal Muscular Atrophy
Cytoskeletal dysregulation in the motoneuron disease Spinal Muscular Atrophy (SMA)
Molecular mechanisms of cytoskeletal dysregulations in Spinal Muscular Atrophy (SMA)
J wave syndromes in patients with spinal and bulbar muscular atrophy
Targeting RNA structure in SMN2 reverses spinal muscular atrophy molecular phenotypes
Development of antisense oligonucleotide combinatorial therapies for spinal muscular atrophy (SMA)
Novel modifiers for inherited neurodegenerative disorders : spinal muscular atrophy and ataxia
Combination disease‐modifying treatment in spinal muscular atrophy: a proposed classification
Experiences from treating seven adult 5q spinal muscular atrophy patients with Nusinersen
Diagnosis and management of spinal muscular atrophy : : Part 2
Treatment satisfaction in 5q-spinal muscular atrophy under nusinersen therapy
Costs of illness of spinal muscular atrophy: a systematic review
Defective Mitochondria Contribute to Impaired Translation in Spinal Muscular Atrophy
Cytoskeletal dysregulation in the motoneuron disease Spinal Muscular Atrophy (SMA)
Molecular mechanisms of cytoskeletal dysregulations in Spinal Muscular Atrophy (SMA)
J wave syndromes in patients with spinal and bulbar muscular atrophy
Targeting RNA structure in SMN2 reverses spinal muscular atrophy molecular phenotypes
Development of antisense oligonucleotide combinatorial therapies for spinal muscular atrophy (SMA)
Novel modifiers for inherited neurodegenerative disorders : spinal muscular atrophy and ataxia
Combination disease‐modifying treatment in spinal muscular atrophy: a proposed classification